CSN2
Basic information
Region (hg38): 4:69955256-69965728
Previous symbols: [ "CASB" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CSN2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 19 | 26 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 19 | 8 | 0 |
Variants in CSN2
This is a list of pathogenic ClinVar variants found in the CSN2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
4-69957275-C-G | not specified | Uncertain significance (Jul 16, 2021) | ||
4-69957288-G-A | not specified | Likely benign (Aug 21, 2023) | ||
4-69957308-G-C | not specified | Uncertain significance (Oct 30, 2024) | ||
4-69957342-G-T | not specified | Uncertain significance (Feb 15, 2023) | ||
4-69957368-T-C | not specified | Uncertain significance (Jan 26, 2022) | ||
4-69957411-G-A | not specified | Uncertain significance (Dec 15, 2023) | ||
4-69957444-A-G | not specified | Uncertain significance (Mar 20, 2024) | ||
4-69957450-G-A | not specified | Likely benign (Jun 24, 2022) | ||
4-69957465-C-T | not specified | Uncertain significance (Mar 20, 2024) | ||
4-69957477-G-A | not specified | Uncertain significance (Apr 08, 2024) | ||
4-69957525-G-A | not specified | Uncertain significance (Aug 28, 2024) | ||
4-69957571-A-T | not specified | Likely benign (Jul 19, 2022) | ||
4-69957572-A-G | not specified | Uncertain significance (Feb 21, 2024) | ||
4-69957584-G-A | not specified | Likely benign (Apr 18, 2023) | ||
4-69957584-G-C | not specified | Uncertain significance (Aug 30, 2021) | ||
4-69957672-C-A | not specified | Likely benign (Aug 30, 2022) | ||
4-69957690-G-T | not specified | Uncertain significance (Jul 10, 2023) | ||
4-69957732-G-T | not specified | Uncertain significance (Dec 21, 2023) | ||
4-69957752-T-G | not specified | Uncertain significance (Jun 18, 2024) | ||
4-69957755-A-T | not specified | Uncertain significance (Oct 04, 2024) | ||
4-69957784-G-C | not specified | Uncertain significance (Jun 27, 2023) | ||
4-69957785-A-G | not specified | Uncertain significance (Dec 12, 2023) | ||
4-69957796-G-A | Likely benign (Feb 01, 2023) | |||
4-69957797-T-C | not specified | Likely benign (Jan 18, 2022) | ||
4-69958938-C-A | not specified | Likely benign (Feb 15, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CSN2 | protein_coding | protein_coding | ENST00000353151 | 6 | 5752 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000718 | 0.504 | 125472 | 0 | 5 | 125477 | 0.0000199 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -1.47 | 158 | 114 | 1.39 | 0.00000516 | 1449 |
Missense in Polyphen | 35 | 22.008 | 1.5903 | 272 | ||
Synonymous | -2.41 | 62 | 42.1 | 1.47 | 0.00000202 | 470 |
Loss of Function | 0.659 | 9 | 11.4 | 0.789 | 4.88e-7 | 132 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000637 | 0.0000616 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000265 | 0.0000264 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000328 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Important role in determination of the surface properties of the casein micelles.;
- Pathway
- Prolactin signaling pathway - Homo sapiens (human);Signaling by ERBB4;Signal Transduction;Glucocorticoid receptor regulatory network;Nuclear signaling by ERBB4;Signaling by ERBB4;Signaling by Receptor Tyrosine Kinases;Signaling events mediated by PTP1B
(Consensus)
Recessive Scores
- pRec
- 0.388
Intolerance Scores
- loftool
- 0.319
- rvis_EVS
- 0.1
- rvis_percentile_EVS
- 61.49
Haploinsufficiency Scores
- pHI
- 0.0778
- hipred
- N
- hipred_score
- 0.276
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0477
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Csn2
- Phenotype
- endocrine/exocrine gland phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan);
Gene ontology
- Biological process
- calcium ion transport;lactation;negative regulation of lactation;negative regulation of cysteine-type endopeptidase activity
- Cellular component
- extracellular region;extracellular space
- Molecular function
- enzyme inhibitor activity;cysteine-type endopeptidase inhibitor activity;calcium ion binding